Finzati - Logo
MDT logo

Medtronic plc

MDT • Medical - Devices
$94.17
▲ +1.07 (+1.15%)
Current price
EarningsSep 2, 11:05 AM UTC
New financial eventQ1 2027Positive

Medtronic plc has reported Q1 2027 financial results

The latest report is predominantly positive and shows an overall improvement in financial performance. Revenue and profitability advanced at a meaningful pace, while the weaker areas should be reviewed in context. The report may attract increased investor attention and price volatility.

Finzati signal
Positive development
Sep 2, 11:05 AM UTC
Improved
+13.73%
Revenue
Improved
+41.35%
Net income
Improved
+120.89%
Free cash flow
Changed
-77.92%
Cash
Improved
-100.00%
Total debt
What changed
↑Revenue increased 13.7% versus the comparable prior period, indicating stronger top-line growth.
↑Net income increased 41.3%, showing improved profitability.
↑Free cash flow increased 120.9%, strengthening cash generation.
↓Total debt declined 100.0%, modestly improving financial flexibility.
Based on newly processed financial statements and comparable prior-period data.This is informational analysis, not investment advice.
Financial data as of: Jul 31, 2026, 12:00 AM UTCLast earnings update: Sep 2, 2026, 11:05 AM UTCLast profile update: Sep 3, 2026, 12:05 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$94.17
Change1.15%
Shares Out1.29B
Market Cap$121.02B
Enterprise Value$119.22B
52W Range73.31 - 106.33
Beta0.57
P/E23.14
P/S3.22
P/FCF19.74
EV/Sales3.18
EV/EBITDA14.04

Investment DNA

How strong this company looks for long-term investors

67
out of 100
Business Quality
Margins, moat, returns
74/100
Financial Strength
Debt, cash, stability
41/100
Growth Potential
Revenue and expansion
46/100
Price Attractiveness
Cheap or expensive today
61/100
Why this score▼
Stable or improving margins · 13.2%Positive free cash flow · 4.23Consistent free cash flow · 5/5Manageable debt level · 0

Analyst view

Analyst sentiment and price target

MDT
Analyst sentiment
Based on 51 analyst votes · 2026-09-05
80/100
Bullish
Bullish
31
Hold
20
Bearish
0
Price Target
2026-09-03
Low
$83.00
Mean
$99.21
Median
$99.50
High
$119.00

Company Overview

IPO: 5/2/1973
Industry: Medical - Devices
P/B i: 0.00
Debt / Equity i: 0.00
Operating Margin: 17.78%
Net Margin: 13.20%
ROE i: -
ROIC: -

Financial Health

Score8 / 20
Debt / Equity: 0.00
Current Ratio: 0.00
Quick Ratio: 0.00
Status: Moderate

Insider Transactions

Recent executive and insider activity

Marinaro Michael
Transaction: 08/20/2026
SELL
Change
-1,084
Price
$92.30
Filing
08/24/2026
Type
SELL
Martha Geoffrey
Transaction: 08/03/2026
BUY
Change
+103,831
Price
Not reported
Filing
08/04/2026
Type
BUY
Martha Geoffrey
Transaction: 08/03/2026
BUY
Change
+273,150
Price
$86.68
Filing
08/04/2026
Type
BUY